Hepatic failure: Difference between revisions

Jump to navigation Jump to search
Line 543: Line 543:
* Chronic liver disease and cirrhosis are the 12(th) leading cause of death in the United States.<ref name="pmid23583430">{{cite journal |vauthors=Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR |title=Underestimation of liver-related mortality in the United States |journal=Gastroenterology |volume=145 |issue=2 |pages=375–82.e1–2 |date=August 2013 |pmid=23583430 |pmc=3890240 |doi=10.1053/j.gastro.2013.04.005 |url=}}</ref>
* Chronic liver disease and cirrhosis are the 12(th) leading cause of death in the United States.<ref name="pmid23583430">{{cite journal |vauthors=Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR |title=Underestimation of liver-related mortality in the United States |journal=Gastroenterology |volume=145 |issue=2 |pages=375–82.e1–2 |date=August 2013 |pmid=23583430 |pmc=3890240 |doi=10.1053/j.gastro.2013.04.005 |url=}}</ref>
* Liver transplantation is the second most common solid organ transplantation, yet less than 10% of global transplantation needs are met at current rates.
* Liver transplantation is the second most common solid organ transplantation, yet less than 10% of global transplantation needs are met at current rates.
==Screening==
*[[Acute liver failure]] is characterized by the presence of coagulopathy (international normalized ratio [INR] >1.5) and any degree of [[encephalopathy]].


==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==

Revision as of 05:32, 31 July 2020

Hepatic failure
ICD-10 K72.9
DiseasesDB 5728
MeSH D017093

WikiDoc Resources for Hepatic failure

Articles

Most recent articles on Hepatic failure

Most cited articles on Hepatic failure

Review articles on Hepatic failure

Articles on Hepatic failure in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hepatic failure

Images of Hepatic failure

Photos of Hepatic failure

Podcasts & MP3s on Hepatic failure

Videos on Hepatic failure

Evidence Based Medicine

Cochrane Collaboration on Hepatic failure

Bandolier on Hepatic failure

TRIP on Hepatic failure

Clinical Trials

Ongoing Trials on Hepatic failure at Clinical Trials.gov

Trial results on Hepatic failure

Clinical Trials on Hepatic failure at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hepatic failure

NICE Guidance on Hepatic failure

NHS PRODIGY Guidance

FDA on Hepatic failure

CDC on Hepatic failure

Books

Books on Hepatic failure

News

Hepatic failure in the news

Be alerted to news on Hepatic failure

News trends on Hepatic failure

Commentary

Blogs on Hepatic failure

Definitions

Definitions of Hepatic failure

Patient Resources / Community

Patient resources on Hepatic failure

Discussion groups on Hepatic failure

Patient Handouts on Hepatic failure

Directions to Hospitals Treating Hepatic failure

Risk calculators and risk factors for Hepatic failure

Healthcare Provider Resources

Symptoms of Hepatic failure

Causes & Risk Factors for Hepatic failure

Diagnostic studies for Hepatic failure

Treatment of Hepatic failure

Continuing Medical Education (CME)

CME Programs on Hepatic failure

International

Hepatic failure en Espanol

Hepatic failure en Francais

Business

Hepatic failure in the Marketplace

Patents on Hepatic failure

Experimental / Informatics

List of terms related to Hepatic failure

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Liver failure; fulminating hepatic failure

Overview

Liver failure is the inability of the liver to perform its normal synthetic and metabolic function as part of normal physiology.

Historical Perspective

Classification

Three forms are recognized:

Pathophysiology

  • The pathophysiology of cerebral edema and hepatic encephalopathy is seen in Acute Liver Failure is multi-factorial and includes altered blood-brain barrier secondary to inflammatory mediators leading to microglial activation, accumulation of glutamine secondary to ammonia crossing the BBB and subsequent oxidative stress leading to depletion of adenosine triphosphate (ATP) and guanosine triphosphate (GTP). This ultimately leads to astrocyte swelling and cerebral edema.

Causes

Etiology of Acute Liver disease

Viruses


Drugs

Metabolic Disease

Toxins

Cardiovascular disease

Autoimmune diseases

Malignant infiltration

Differential Diagnosis

Autoimmune hepatitis must be differentiated from other diseases that cause jaundice, nausea and vomiting, abdominal pain, arthragia, and hepatomegaly such as Hepatitis A,B,C, E, drug induced hepatitis, CMV hepatitis, EBV hepatitis, alcoholic hepatitis, Primary biliary cirrhosis and Primary sclerosing cholangitis.[7][8][9][10][11][12][13][14][15]

Classification of jaundice based on etiology Disease History and clinical manifestations Diagnosis
Lab Findings Other blood tests Other diagnostic
Family history Fever RUQ Pain Pruritis AST ALT ALP BLR Indirect BLR Direct Viral serology
Jaundice Hepatocellular Jaundice Infiltrative liver disorders: Hemochromatosis, amyloidosis + - -/+ - ↑/N ↑/N N - Ferritin ↑ (hemochromatosis) Liver biopsy
Wilson's disease + - -/+ - N ↑/N N - ↑ Serum ceruloplasmin Liver biopsy
Viral hepatitis - -/+ - - N ↑/N N + Specific viral antibody for each type -
Alcoholic hepatitis - -/+ -/+ - ↑↑ N ↑/N N - - -
Drug induced hepatitis - -/+ - - N ↑/N N - - -
Autoimmune hepatitis -/+ - - -/+ N ↑/N N - Anti-LKM antibody Liver biopsy
Cirrhosis -/+ -/+ -/+ - ↑/N ↑/N ↑/N -/+ Low platate Small liver on ultrasond
Nonalcoholic steatohepatitis -/+ - - - N ↑/N N - Dyslipidemia liver biopsy
Ischemic hepatopathy -/+ - -/+ - N ↑/N N - Cardiovascular risk factors -
Cholestatic Jaundice Common bile duct stone -/+ - + + N N N - Dilated ducts on ultrasound CT/ERCP
Hepatitis A (cholestatic type) - -/+ + + N/↑ N/↑ N + HAV- Ab Abdominal ultrasound
EBV / CMV hepatitis - -/+ + + N N N + Positive serology -
Primary biliary cirrhosis -/+ - -/+ + N/↑ N/↑ N - AMA positive Liver biopsy
Primary sclerosing cholangitis -/+ - -/+ + N/↑ N/↑ N - ↑Autoantibodies (P-ANCA), hypergammaglobulinemia MRCP,

Liver biopsy

Sickle cell disease + - - +/- N/↑ N/↑ N - Genetic testing
Pancreatic carcinoma + - -/+ -/+ N/↑ N/↑ N - - CT scan for diagnosis
AIDS cholangiopathy - - -/+ -/+ N/↑ N/↑ N - HIV Ab Ultrasound or ERCP
Parasites induces cholestasis - - -/+ -/+ N/↑ N/↑ N - Serology Ultrasound or ERCP
Intrahepatic cholestasis of pregnancy -/+ - -/+ + N - Thrombocytopenia Diagnosed clinically
Isolated Jaundice Crigler-Najjar type 2 + - - - N N N - Genetic testing
Gilbert + - - - N N N - Genetic testing
Rotor syndrome + - - - N N N N - Genetic testing Liver biopsy
Dubin-Johnson syndrome + - - - N N N N - Genetic testing Liver biopsy
Hereditary spherocytosis + - -/+ - N N N N - Genetic testing Osmotic fragility
G6PD deficiency + - - - N N N N - Genetic testing
Thalassemia + - - - N N N N - Genetic testing
Paroxysmal nocturnal hemoglobinuria - - - - N N N N - Flocytometery
Immune hemolysis - -/+ - - N N N N - Autoantibodies
Hematoma - -/+ - - N N N N - Anemia Truma or surgery in history


Epidemiology and Demographics

  • Acute liver failure affects approximately 2,000–3,000 Americans each year.[16]
  • Chronic liver disease and cirrhosis are the 12(th) leading cause of death in the United States.[17]
  • Liver transplantation is the second most common solid organ transplantation, yet less than 10% of global transplantation needs are met at current rates.

Natural History, Complications and Prognosis

  • Acute liver failure (Hyperacute and subacute) is a rare but serious clinical syndrome characterized by the sudden loss of hepatic function in a person without evidence of preexisting liver disease (Exceptions to this definition include Wilson's disease, reactivation of hepatitis B virus infection, and autoimmune hepatitis)[16]

Prognosis

The King's College Criteria (KCC) may be used.[16]

Diagnosis

The following evaluation is recommended to help determine the etiology of liver failure. Determination of etiology assists in directing therapy and estimating prognosis:

History and Symptoms

  • Obtain a detailed medical history from the patient and/or family, including the first onset of the symptom(s); all medications used over the last 6 months, including prescription medications, over-the-counter agents, herbal supplements, wild mushrooms, or other alternatives/complementary therapies;
  • Obtain a detailed history of current and prior substance use; current or prior depression (including assessment of suicidality), anxiety, psychosis, or

other mental illness; viral prodrome; and recent travel.

Physical Examination

  • Complete physical examination should be performed.
  • Assessment of mental status, the neurologic examination, and the fundoscopic examination in patients with Hepatic Encephalopathy of stage 2 or greater.

Laboratory Findings

  • laboratory tests are recommended for establishing an etiology and determining the prognosis of Acute liver failure:
  • Hepatic panel
  • Complete blood count with differential
  • Prothrombin time/international normalized ratio
  • Metabolic panel
  • Magnesium level
  • Phosphorus level
  • Amylase and lipase levels
  • Toxicology screen (including acetaminophen and salicylate levels)
  • Factor V level
  • a-fetoprotein level
  • Arterial lactate level
  • Arterial blood gas level
  • Arterial ammonia level (in patients with stage 2 or greater hepatic encephalopathy)
  • Viral hepatitis serologies: Hepatitis B surface antigen (hepatitis delta immunoglobulin (Ig)G if the surface antigen is positive), Hepatitis B core IgM, Hepatitis A IgM, Hepatitis E IgG (if positive, ribonucleic acid testing should be ordered in select patients), Hepatitis C antibody
  • HIV antibody
  • Blood and urine cultures
  • Urinalysis
  • Blood type
  • Serum pregnancy test (for patients with childbearing potential)
  • Thromboelastogram
  • Diagnostic transjugular liver biopsy

Imaging

  • Abdominal ultrasound with Doppler to confirm portal and hepatic vein patency
  • Non-contrast computed tomography (CT) scan of the head for patients with Hepatic encephalopathy

Treatment

Effective medical Therapies for specific causes of liver failure and hepatic encephalopathy.[16]

  • Acetaminophen intoxication Oral NAC: 140 mg/kg loading dose, then 70 mg/kg every 4 hours until discontinued by hepatology or transplantation surgery attending physician

IV NAC: 150 mg/kg loading dose, then 50 mg/kg IV over 4 hours, then 100 mg/kg IV over 16 hours as a continuous infusion until discontinued by hepatology or transplantation surgery attending physician

  • Amanita phalloides(mushroom intoxication) Charcoal: via NGT every 4 hours alternating with silymarin, Penicillin G: 1 g/kg/day IV and NAC (Dosing as for acetaminophen

overdose.),Silymarin: 300 mg PO/NGT every 12 hours,Legalon-SIL: 5 mg/kg/day IV (given in 4 divided doses) or 5 mg/kg IV loading dose followed by 20 mg/kg/day via continuous infusion

Treatment of Hepatic Encephalopathy

Liver transplantation: One of the most important, yet difficult, aspects of care for patients with Acute Liver failure is the determination of the need for urgent liver transplantation. We recommend early and rapid evaluation for transplantation candidacy.


Contraindicated medications

Severe hepatic failure is considered an absolute contraindication to the use of the following medications:

The ALFSG index is a newer option that may be more accurate.[18]

References

  1. Riordan SM, Williams R (May 2008). "Perspectives on liver failure: past and future". Semin. Liver Dis. 28 (2): 137–41. doi:10.1055/s-2008-1073113. PMID 18452113.
  2. Bernuau J, Rueff B, Benhamou JP (May 1986). "Fulminant and subfulminant liver failure: definitions and causes". Semin. Liver Dis. 6 (2): 97–106. doi:10.1055/s-2008-1040593. PMID 3529410.
  3. 3.0 3.1 O'Grady JG, Schalm SW, Williams R (July 1993). "Acute liver failure: redefining the syndromes". Lancet. 342 (8866): 273–5. doi:10.1016/0140-6736(93)91818-7. PMID 8101303.
  4. Jalan R, Williams R (2002). "Acute-on-chronic liver failure: pathophysiological basis of therapeutic options". Blood Purif. 20 (3): 252–61. doi:10.1159/000047017. PMID 11867872.
  5. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V (June 2013). "Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis". Gastroenterology. 144 (7): 1426–37, 1437.e1–9. doi:10.1053/j.gastro.2013.02.042. PMID 23474284.
  6. Schuppan D, Afdhal NH (March 2008). "Liver cirrhosis". Lancet. 371 (9615): 838–51. doi:10.1016/S0140-6736(08)60383-9. PMC 2271178. PMID 18328931.
  7. Selmi C, Bowlus CL, Gershwin ME, Coppel RL (2011). "Primary biliary cirrhosis". Lancet. 377 (9777): 1600–9. doi:10.1016/S0140-6736(10)61965-4. PMID 21529926.
  8. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ (2009). "Primary biliary cirrhosis". Hepatology. 50 (1): 291–308. doi:10.1002/hep.22906. PMID 19554543.
  9. Koff RS (1998). "Hepatitis A". Lancet. 351 (9116): 1643–9. doi:10.1016/S0140-6736(98)01304-X. PMID 9620732.
  10. Ciocca M (2000). "Clinical course and consequences of hepatitis A infection". Vaccine. 18 Suppl 1: S71–4. PMID 10683554.
  11. Fargo MV, Grogan SP, Saguil A (2017). "Evaluation of Jaundice in Adults". Am Fam Physician. 95 (3): 164–168. PMID 28145671.
  12. Leevy CB, Koneru B, Klein KM (1997). "Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease". Gastroenterology. 113 (3): 966–72. PMID 9287990.
  13. Hov JR, Boberg KM, Karlsen TH (2008). "Autoantibodies in primary sclerosing cholangitis". World J. Gastroenterol. 14 (24): 3781–91. PMC 2721433. PMID 18609700.
  14. Bond LR, Hatty SR, Horn ME, Dick M, Meire HB, Bellingham AJ (1987). "Gall stones in sickle cell disease in the United Kingdom". Br Med J (Clin Res Ed). 295 (6592): 234–6. PMC 1247079. PMID 3115390.
  15. Malakouti M, Kataria A, Ali SK, Schenker S (2017). "Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do?". J Clin Transl Hepatol. 5 (4): 394–403. doi:10.14218/JCTH.2017.00027. PMC 5719197. PMID 29226106.
  16. 16.0 16.1 16.2 16.3 Patton H, Misel M, Gish RG (March 2012). "Acute liver failure in adults: an evidence-based management protocol for clinicians". Gastroenterol Hepatol (N Y). 8 (3): 161–212. PMC 3365519. PMID 22675278.
  17. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR (August 2013). "Underestimation of liver-related mortality in the United States". Gastroenterology. 145 (2): 375–82.e1–2. doi:10.1053/j.gastro.2013.04.005. PMC 3890240. PMID 23583430.
  18. Rutherford A, King LY, Hynan LS, Vedvyas C, Lin W, Lee WM; et al. (2012). "Development of an accurate index for predicting outcomes of patients with acute liver failure". Gastroenterology. 143 (5): 1237–43. doi:10.1053/j.gastro.2012.07.113. PMC 3480539. PMID 22885329.

See Also

Template:Gastroenterology

cs:Jaterní selhání sv:Leversvikt ur:فشل جگری


Template:WikiDoc Sources